The expression of TRAF6, a TLR4 downstream signaling molecule, was higher in SLE patients than in HC (Fig. 3i, 151.1 ± 76.3% versus 100.0 ± 45.3%, p = 0.002). Here, TLR4 is linked to systemic lupus erythematosus.